1,2,3,4,6-Penta-O-galloyl-d-glucose Interrupts the Early Adipocyte Lifecycle and Attenuates Adiposity and Hepatic Steatosis in Mice with Diet-Induced Obesity
暂无分享,去创建一个
C. Liaw | B. Green | Wei-Jan Huang | Hui-Kang Liu | Chung-Kuang Lu | Lin-Chien Lee | Chia-Chuan Chang | Cheng Huang | Wentao He | Hsin-Ying Han | Ashish Rao Sathyanarayana
[1] Shuang Zhao,et al. Inhibitory effects and molecular mechanisms of pentagalloyl glucose in combination with 5-FU on aggressive phenotypes of HepG2 cells , 2021, Natural product research.
[2] Qianqian Li,et al. β-glucan attenuates cognitive impairment via the gut-brain axis in diet-induced obese mice , 2020, Microbiome.
[3] Yong Cao,et al. Mechanism of Pentagalloyl Glucose in Alleviating Fat Accumulation in Caenorhabditis elegans. , 2019, Journal of agricultural and food chemistry.
[4] Lie-Chwen Lin,et al. Effects of boschnaloside from Boschniakia rossica on dysglycemia and islet dysfunction in severely diabetic mice through modulating the action of glucagon-like peptide-1. , 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[5] H. Ashrafian,et al. Current treatments for obesity. , 2019, Clinical medicine.
[6] M. Sabbaghian,et al. Glycyrrhizin Improves Fatty Liver Symptoms, Increases Adiponectin and Reduces UCP2 Expression in Wistar Rats , 2019, Proceedings of the National Academy of Sciences, India Section B: Biological Sciences.
[7] Chun-mei Li,et al. Penta-O-galloyl-β-d-glucose, a hydrolysable tannin from Radix Paeoniae Alba, inhibits adipogenesis and TNF-α-mediated inflammation in 3T3-L1 cells. , 2019, Chemico-biological interactions.
[8] Ross A. Hammond,et al. The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report , 2019, The Lancet.
[9] W. Jia,et al. Regulation of microbiota—GLP1 axis by sennoside A in diet-induced obese mice , 2019, Acta pharmaceutica Sinica. B.
[10] Cristóbal N. Aguilar,et al. Pentagalloylglucose (PGG): A valuable phenolic compound with functional properties , 2017 .
[11] S. Jain,et al. Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction , 2017, International journal of molecular sciences.
[12] Y. Mu,et al. Exendin-4 Upregulates Adiponectin Level in Adipocytes via Sirt1/Foxo-1 Signaling Pathway , 2017, PloS one.
[13] Ren-Shyan Liu,et al. Evaluation of the In Vivo Therapeutic Effects of Radix Paeoniae Rubra Ethanol Extract with the Hypoglycemic Activities Measured from Multiple Cell-Based Assays , 2016, Evidence-based complementary and alternative medicine : eCAM.
[14] Y. Iwakiri. Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase , 2015, Clinical and molecular hepatology.
[15] X. Liu,et al. Glucose- and Triglyceride-lowering Dietary Penta-O-galloyl-α-D-Glucose Reduces Expression of PPARγ and C/EBPα, Induces p21-Mediated G1 Phase Cell Cycle Arrest, and Inhibits Adipogenesis in 3T3-L1 Preadipocytes , 2015, Experimental and Clinical Endocrinology & Diabetes (Barth).
[16] K. Soliman,et al. 1,2,3,4,6-Penta-O-galloylglucose within Galla Chinensis Inhibits Human LDH-A and Attenuates Cell Proliferation in MDA-MB-231 Breast Cancer Cells , 2015, Evidence-based complementary and alternative medicine : eCAM.
[17] Dao-wu Wang,et al. The ER Stress-Mediated Mitochondrial Apoptotic Pathway and MAPKs Modulate Tachypacing-Induced Apoptosis in HL-1 Atrial Myocytes , 2015, PloS one.
[18] A. Vella,et al. Effects of GLP-1 on appetite and weight , 2014, Reviews in Endocrine and Metabolic Disorders.
[19] Patrice D Cani,et al. Gut microbiota and GLP-1 , 2014, Reviews in Endocrine and Metabolic Disorders.
[20] Cheng Jiang,et al. Involvement of autophagy induction in penta-1,2,3,4,6-O-galloyl-β-D-glucose-induced senescence-like growth arrest in human cancer cells , 2014, Autophagy.
[21] Xiaozhuo Chen,et al. Biological and biomedical functions of Penta-O-galloyl-d-glucose and its derivatives , 2014, Journal of Natural Medicines.
[22] Qiang Xu,et al. Mitochondria-Dependent Apoptosis of Con A-Activated T Lymphocytes Induced by Asiatic Acid for Preventing Murine Fulminant Hepatitis , 2012, PloS one.
[23] F. Karpe,et al. Fatty Acids, Obesity, and Insulin Resistance: Time for a Reevaluation , 2011, Diabetes.
[24] Yun-Lian Lin,et al. Pharmacological evaluation of insulin mimetic novel suppressors of PEPCK gene transcription from Paeoniae Rubra Radix. , 2011, Journal of ethnopharmacology.
[25] Yan Liu,et al. Insulin receptor signaling activated by penta-O-galloyl-α-d-glucopyranose induces p53 and apoptosis in cancer cells , 2011, Apoptosis.
[26] M. Pk,et al. Obesity and Disease Association: A Review , 2011 .
[27] S. Rayalam,et al. Phytochemicals and adipogenesis , 2010, BioFactors.
[28] W. Tsai,et al. The novel anti-hyperglycemic effect of Paeoniae radix via the transcriptional suppression of phosphoenopyruvate carboxykinase (PEPCK). , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[29] D. Langin,et al. Lipolysis and lipid mobilization in human adipose tissue. , 2009, Progress in lipid research.
[30] J. Hebebrand,et al. [Obesity and overweight]. , 2009, Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie.
[31] S. Rayalam,et al. Phytochemicals and regulation of the adipocyte life cycle. , 2008, The Journal of nutritional biochemistry.
[32] J. Holst,et al. Glucagon-like peptide-1, glucose homeostasis and diabetes. , 2008, Trends in molecular medicine.
[33] Xiaozhuo Chen,et al. Antidiabetes and Anti-obesity Activity of Lagerstroemia speciosa , 2007, Evidence-based complementary and alternative medicine : eCAM.
[34] S. Kahn,et al. Mechanisms linking obesity to insulin resistance and type 2 diabetes , 2006, Nature.
[35] Xiaozhuo Chen,et al. Synthesis and structure-activity relationship study of antidiabetic penta-O-galloyl-D-glucopyranose and its analogues. , 2006, Journal of medicinal chemistry.
[36] Fang Liu,et al. Natural anti-diabetic compound 1,2,3,4,6-penta-O-galloyl-D-glucopyranose binds to insulin receptor and activates insulin-mediated glucose transport signaling pathway. , 2005, Biochemical and biophysical research communications.
[37] E. Whiteman,et al. Insulin signaling in the adipocyte , 2000, International Journal of Obesity.
[38] K. Khanbabaee,et al. Efficient Total Synthesis of the Natural Products 2,3,4,6-Tetra-O- galloyl-D-glucopyranose (V), 1,2,3,4,6-Penta-O-galloyl-β-D- glucopyranose and the Unnatural 1,2,3,4,6-Penta-O-galloyl-α-D- glucopyranose. , 1997 .
[39] G. G. Gross,et al. Biosynthesis of gallotannins: beta-glucogallin-dependent formation of 1,2,3,4,6-pentagalloylglucose by enzymatic galloylation of 1,2,3,6-tetragalloylglucose. , 1989, Archives of biochemistry and biophysics.
[40] F. Hu,et al. Obesity , 2017, Nature Reviews Disease Primers.
[41] A. Sniderman,et al. The adipocyte life cycle hypothesis. , 2006, Clinical science.